Search company, investor...
Search

Predict your next investment

Asset/Investment Management
paratusinvestment.com

See what CB Insights has to offer

Investments

13

Portfolio Exits

2

About Paratus Investment

Paratus Investment pursues long-term value investments in the consumer goods, healthcare, raw materials, and energy sectors.

Paratus Investment Headquarters Location

City Airport Tower, 23rd Floor, #2302 36, Teheran-ro 87-gil, Gangnam-gu

Seoul, 06164,

South Korea

+82 (02) 2016- 5123

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Paratus Investment News

Genome Insight Raises USD 23M in Series B

May 2, 2022

Genome Insight, a San Diego, CA-based Whole Genome Sequence analysis and interpretation company, raised USD 23 in Series B funding. The round was led by Dunamu & Partners with participation from InterVest, Signite Partners, KC, and VNTG Corporation, as well as existing investors DSC Investment, Paratus Investment, and Schmidt.

Paratus Investment Investments

13 Investments

Paratus Investment has made 13 investments. Their latest investment was in UPPthera as part of their Series B on May 5, 2022.

CBI Logo

Paratus Investment Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/18/2022

Series B

UPPthera

$21.96M

Yes

3

4/28/2022

Series B

Genome Insight

$23M

No

4

4/26/2022

Series B

JL Chem

$27.5M

Yes

1

3/23/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

3/14/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/18/2022

4/28/2022

4/26/2022

3/23/2022

3/14/2022

Round

Series B

Series B

Series B

Series A

Series A

Company

UPPthera

Genome Insight

JL Chem

Subscribe to see more

Subscribe to see more

Amount

$21.96M

$23M

$27.5M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

4

1

10

10

Paratus Investment Portfolio Exits

2 Portfolio Exits

Paratus Investment has 2 portfolio exits. Their latest portfolio exit was Genome & Company on December 26, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/26/2018

IPO

$99M

Public

2

12/21/2018

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/26/2018

12/21/2018

Exit

IPO

IPO

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Public

Subscribe to see more

Sources

2

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.